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ABSTRACT 
Mucosal-associated invariant T (MAIT) cells produce inflammatory cytokines and cytotoxic 
granzymes in response to by-products of microbial riboflavin synthesis. Although MAIT cells 
are protective against some pathogens, we reasoned that they might contribute to pathology in 
chronic bacterial infection. We observed MAIT cells in proximity to Helicobacter 
pyloribacteria in human gastric tissue, and so, using MR1-tetramers, we examined whether 
MAIT cells contribute to chronic gastritis in a mouse H. pylori SS1 infection model. 
Following infection, MAIT cells accumulated to high numbers in the gastric mucosa of wild-
type C57BL/6 mice, and this was even more pronounced in MAIT TCR transgenic mice or in 
C57BL/6 mice where MAIT cells were preprimed by Ag exposure or prior infection. Gastric 
MAIT cells possessed an effector memory Tc1/Tc17 phenotype, and were associated with 
accelerated gastritis characterized by augmented recruitment of neutrophils, macrophages, 
dendritic cells, eosinophils, and non-MAIT T cells and by marked gastric atrophy. Similarly 
treated MR1−/−mice, which lack MAIT cells, showed significantly less gastric pathology. 
Thus, we demonstrate the pathogenic potential of MAIT cells in Helicobacter-associated 
immunopathology, with implications for other chronic bacterial infections. 
 
 
INTRODUCTION 
 
Mucosal-associated invariant T (MAIT) cells are a subset of T cells, which are abundant in 
humans (1–8% in blood), but relatively rare (∼0.1% in blood) in specific pathogen-free 
(SPF)-housed laboratory mice (1–3). MAIT cells typically express a semi-invariant αβ TCR, 
which in humans comprises TRAV1-TRAJ33 (Vα7.2-Jα33/20/12) TCR α-chain 
preferentially assembled with TRBV20+ (Vβ2) or TRBV6+ (Vβ13) TCR β-chains. In mice 
TRAV1-TRAJ33 (Vα19-Jα33) is mostly paired with TRBV19 (Vβ6) or TRBV13 (Vβ8) 
(3, 4). MAIT TCRs are restricted by the monomorphic MHC-related protein 1 (MR1) (5). 
 
MR1 presents vitamin B–related Ags, including 5-(2-oxopropylideneamino)-6-D-
ribitylaminouracil (5-OP-RU) and 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-
RU), which are derived from a precursor of microbial riboflavin (vitamin B2) biosynthesis 
and activate MAIT cells in vitro (6–8). Indeed, a correlation between the presence of the 
riboflavin synthesis pathway in diverse microbes, including bacteria and yeast, with MAIT 
cell activation, led to the discovery of this pathway as furnishing this new class of Ag (6, 9). 
In contrast, microbes that do not synthesize riboflavin, such as Listeria monocytogenes 
and Enterococcus faecalis, do not activate MAIT cells in a TCR-dependent manner (10). 
Thus, MAIT cells, which are enriched in tissues including lungs, intestine, and liver, are 
ideally placed to detect metabolically active microbes producing these Ags at mucosal sites. 
MAIT cells have been shown to respond, in vivo, to bacteria that produce the riboflavin-
derived Ags, or to synthetic 5-OP-RU, in the presence of TLR agonists (1). 
 
MAIT cells rapidly secrete cytokines (including IFN-γ, IL-17, and TNF) upon stimulation 
and play a protective role in some model bacterial infections, including Klebsiella 
pneumoniae, Mycobacterium tuberculosis, M. bovis bacillus Calmette–Guérin, 
and Francisella tularensis (11–14). They can also be activated in a TCR-independent manner 
by cytokines or viral infections (15, 16). Correlations between MAIT cell number and disease 
severity have been demonstrated for a range of chronic inflammatory conditions, including 
multiple sclerosis, rheumatoid arthritis, inflammatory bowel diseases, celiac disease, and 
ankylosing spondylitis (reviewed in Ref. 17), suggesting that MAIT cells may also contribute 
to immunopathology. The basis of these correlative associations could involve MAIT cell 
activation, but might also be attributable to patient treatment (18), which has not been 
considered in all studies. Few studies to date have attempted to understand the potential role 
of MAIT cells in immunopathology. Notably, Helicobacter pylori, which synthesizes 
riboflavin, and thus likely produces the known MAIT cell stimulatory Ags, has been shown 
to stimulate human MAIT cells in vitro (19). Indeed, one study showed a reduction in MAIT 
cell numbers in H. pylori–infected patients’ blood versus healthy controls, and human gastric 
MAIT cells can produce cytokines in response to H. pylori–infected macrophages in vitro 
(19). Hence, we reasoned such a role might be demonstrated in unresolved (i.e., chronic) 
bacterial infection and tested this idea in a model of H. pylori gastritis. 
 
H. pylori are Gram-negative extracellular bacteria that colonize the stomach. A large 
proportion of the world’s population is infected with H. pylori and in most people, unless 
treated with antibiotics, the infection persists for decades. Most infected individuals remain 
asymptomatic, but 15–20% develop severe gastritis and overt disease such as peptic ulcers. A 
smaller proportion (1–3% of cases) develops gastric adenocarcinoma and fewer again (0.1%) 
MALT lymphoma (20). Infection with H. pylori induces both innate and adaptive immune 
responses by the host, generally Th1-biased, and tempered by regulatory T cells (reviewed in 
Ref. 21). 
 
Mouse models of H. pylori infection have been widely used to understand disease 
development, and show the importance of CD4+ T cells including Th17 cells (22, 23). 
However, to date, no analysis of MAIT cells in mouse models of H. pylori has been reported, 
perhaps in part because of the low abundance of MAIT cells in mice and low numbers of 
lymphocytes in uninfected stomachs, and because MR1-tetramers that precisely identify 
murine MAIT cells have only recently been developed (2, 3, 6). The production of 
proinflammatory cytokines including IL-17 and IFN-γ by MAIT cells (2, 12, 24) suggests a 
potential role in the chronic inflammation (gastritis) that is characteristic of H. 
pylori infection, and possibly in the subsequent development of more severe MALT 
lymphoma and adenocarcinoma that occur in some patients. Because the role of MAIT cells 
in the immune response to H. pylori remains unclear, this circumstantial evidence prompted 
us to address this question experimentally, using Ag-specific MR1-5-OP-RU tetramers 
(MR1-tetramers) to detect MAIT cells (1–3, 6) thereby removing ambiguity inherent in 
surrogate markers of these cells. Here we use both Vα19iCα−/−MAIT TCR transgenic mice 
and wild-type (wt) C57BL/6 mice with preboosted MAIT cells to investigate the role of 
MAIT cells in H. pylori infection, revealing for the first time, to our knowledge, their 
pathogenic potential in chronic bacterial infection. 
 
 
MATERIAL AND METHODS 
Human gastric tissue and immunofluorescence staining 
Human gastric tissue, normally discarded following sleeve gastrectomy bariatric surgery, was 
obtained through The Avenue Hospital, Melbourne, with written consent from patients, after 
approval from The University of Melbourne and The Avenue Human Research Ethics 
Committees. All patients were female, between 27 and 57 y of age. Gastric mucosa was 
dissected from underlying tissue, rinsed with ice-cold HBSS, snap frozen in OCT and 
sectioned (8 μm) using a Leica CM3050 S cryostat. Acetone-fixed tissue was blocked with 
serum-free protein block (DAKO) for 30 min and/or 10% goat serum (Sigma) at room 
temperature (RT), prior to detection with primary Abs targeting CD3 (CD3-12; Bio-Rad), 
TRAV1-2 (3C10; BioLegend), and H. pylori rabbit polyclonal (DAKO) diluted in 2.5% 
normal goat serum, followed by Alexa Fluor 647 goat anti-rat, Alexa Fluor 488 goat anti-
mouse, and Alexa Fluor 555 goat anti-rabbit secondary Abs, respectively (Life 
Technologies). Nuclei were counterstained with Hoechst 33342 (Life Technologies) prior to 
mounting with ProlongGold (Life Technologies). Slides were analyzed using Carl Zeiss 
LSM700 confocal microscope with a 20× objective and Carl Zeiss Zen software at the 
Biological Microscopy Platform at The University of Melbourne. Images were prepared 
using FIJI/ImageJ software. 
 
Human PBMC and gastric cell preparations and flow cytometry 
 
Following dissection of mucosa, tissue was chopped into 2–5 mm pieces, then incubated in 
EDTA/BSS, 5% FCS, 1 mM DTT, and shaken at 150 rpm for 15 min at 37°C. Released cells 
were passed through a 70-μm strainer and washed in EDTA/BSS + 5% FCS. PBMCs were 
prepared by Ficoll-Paque density gradient separation from ∼20 ml fresh blood. Cells were 
frozen in FCS + 10% DMSO and stored in liquid N2 until use. Upon thawing, cells were 
washed, rested for 1–2 h and filtered (70 μm) before staining. Cells (from 3 × 105 to 2 × 106) 
were stained with Ab to CD3 (OKT3 AF700 or PE-CF594; eBioscience), CD161 (HP-3G10, 
PE-Cy7; BioLegend), TCR Vα7.2 (3C10, BV875; BioLegend), human MR1-tetramer (PE, 
prepared in-house) and 7AAD (7-aminoactinomycin D, 1:500) or Live/Dead Aqua 
(ThermoFisher 1:500), and were fixed with 1% paraformaldehyde before analysis on a BD 
LSR Fortessa Flow Cytometer (BD Biosciences). Data were analyzed with FlowJo software 
(v10; Tree Star). Cells were gated sequentially for lymphocytes (forward scatter [height] 
versus side scatter [height]), single cells (forward scatter [height] versus forward scatter 
[area]), live cells (7AAD−), T cells (CD3+), and MAIT cells (CD161+MR1-tetramer+). 
 
Activation of Jurkat.MAIT cells and MR1 upregulation 
 
MAIT cell reporter activation and MR1 expression upregulation assays were performed 
essentially as previously reported (9). Jurkat cells overexpressing the MAIT TCR clone AF-7 
(Jurkat.MAIT) were tested for activation by coincubation with compounds and C1R cells 
overexpressing MR1 (C1R.MR1) for 16 h. Cells were subsequently stained with PE-Cy7–
conjugated anti-CD3 (UCHT1, 1:300; eBioscience), and APC-conjugated anti-CD69 (1:25; 
BD Biosciences) before analysis on a FACSCanto II (BD Biosciences) flow cytometer. 
Activation of Jurkat.MAIT was measured by an increase in surface CD69 expression. In 
some experiments, blocking Ab (prepared in-house from hybridoma anti-MR1 mAb 26.5, a 
gift from Dr. T. Hansen, Washington University School of Medicine, St. Louis, MO) (25) or 
isotype control 8A5 (prepared in-house) were added (final 10 μg/ml) prior to addition of 
stimuli. For MR1 expression, cells were additionally stained with biotinylated anti-MR1 mAb 
26.5, followed by PE-conjugated streptavidin. Control Jurkat.LC13 cells (9) were activated 
by C1R cells expressing HLA-B8 in the presence of the EBV peptide FLRGRAYGL (FLR). 
Compounds and immunogens 
 
5-OP-RU was prepared as described previously (26). 6-Formyl pterin (6-FP) was purchased 
from Schircks Laboratories (Jona, Switzerland). TLR2/6 agonist Pam2Cys (27) was 
chemically synthesized and functionally verified. 
 
Mice 
 
All C57BL/6 mice, MR1−/− mice, Vα19iCα−/−MR1+ mice, and Vα19iCα−/−MR1−/− mice (all 
on C57BL/6 genetic background) were bred and housed in the Biological Research Facility 
of the Doherty Institute. MR1−/− mice were generated by breeding Vα19iCα−/−MR1−/− mice 
(28) obtained from S. Gilfillan (Washington University School of Medicine, St. Louis, MO) 
with C57BL/6 mice, and intercrossing of F1 mice, and verified as described (1). Female mice 
aged between 6 and 12 wk were used in all experiments following approval by The 
University of Melbourne Animal Ethics Committee. 
 
Bacterial culture and infection 
 
H. pylori SS1 (29) was cultivated as described previously (30). Mice were infected 
orogastrically with H. pylori (107 CFU) suspended in 100 μl brain heart infusion broth 
(BHI). Salmonella enterica serovar Typhimurium BRD509 (31) and the S. Typhimurium 
BRD509ΔribDH mutant (1) have been previously described. For S. Typhimurium 
ΔribDH growth, culture medium (Luria broth) was supplemented with 20 μg/ml riboflavin. 
Mice were inoculated under isofluorane anesthesia with S. Typhimurium BRD509 (106 CFU) 
or ΔribDH (107 CFU unless otherwise stated) or Ags (1.52 μM 5-OP-RU or 6-FP alone in 50 
μl, or in 45 μl plus 5 μl of 20 nmol Pam2Cys) prepared in 50 μl PBS, via the intranasal route. 
 
Preparation of organs and isolation of cells 
 
Single cell suspensions of lungs, blood, mesenteric lymph nodes, and spleen were prepared as 
described previously (1). Gastric immune cells were isolated by perfusion from longitudinally 
halved stomachs, as described previously (32). 
 
Generation of MR1-tetramers 
 
Mouse and human MR1-5-OP-RU labeled with BV421 or PE and MR1-6-FP (unlabeled) 
tetramers were generated as described previously (6) and prepared simultaneously. 
Abs and flow cytometry 
 
Abs against CD19 (1D3, PerCP-Cy 5.5), CD3 (UCHT1, PE or 145-2C11, PE-Cy7), CD4 
(GK1.5, APC-Cy7), CD45.2 (104, FITC), CD69 (FN50, APC), CD8α (53-6.7, PE), and 
TCRβ (H57-597, APC or FITC) were purchased from BD Pharmingen. Abs against MHC II 
(M5, Alexa Fluor 700), PLZF (Mags.21F7, PE), RORγt (B2D, APC), and T-bet (4B10, PE-
Cy7) were purchased from eBioscience. To block nonspecific staining, cells were incubated 
with MR1-6-FP tetramer (unlabeled, 1:100) and anti–Fc receptor (2.4G2) for 15 min at RT 
prior to Ab staining. Cells were then incubated at RT with Ab cocktails including MR1-
tetramer in PBS/2% FCS. Cells were then further incubated with 7-aminoactinomycin D (5 μl 
per sample) for 10 min in the dark at RT and fixed with 1% paraformaldehyde prior to 
analysis on LSR Fortessa (BD Biosciences). Data were analyzed with FlowJo software 
(Version 10, Tree Star). Cell counts were obtained using blank calibration particles (BD 
Pharmingen) or by flow rate calibration (33) (for Fig. 4C). Transcription factor staining was 
performed using a commercial transcription buffer staining set (eBioscience) according to the 
manufacturer’s instructions. 
 
Assessment of gastritis 
 
Longitudinally dissected half stomachs were fixed in 10% neutral buffered formalin, 
embedded in paraffin; 5-μm sections were stained with H&E and scored by a blinded 
operator under light microscopy. A pathologist also scored sections independently and the 
grading system is based on a previously described system (34) with modifications. Briefly, 
inflammation was assessed in two separate tissue sections for each animal using three 
parameters: 1) neutrophil infiltration and 2) lymphocyte infiltration: scored 0–4 on the basis 
of number of cells and whether widespread or multifocal infiltrate was observed, and 3) 
atrophy: scored 0–4 on the basis of loss of chief and parietal cells from the gastric glands. 
 
PCR amplification and sequencing of TCRs 
 
Single cells were sorted from S. Typhimurium BRD509-primed, H. pylori–infected C57BL/6 
mouse stomachs on a FACSAria flow cytometer. PCR amplification and TCR sequencing 
was performed as previously described (3). 
 
Statistical analysis 
 
Statistical tests were performed using Prism software (version 6; GraphPad software, La 
Jolla, CA). Comparisons between groups were performed using one-way ANOVA, 
Student t test, Mann–Whitney, Spearman correlation, or Kruskal–Wallis test as indicated in 
the figure legends. 
 
 
RESULTS 
H. pylori have a riboflavin biosynthesis pathway and are capable of activating MAIT 
reporter cells 
 
We first tested whether H. pylori synthesize Ags that stimulate MAIT cells. Previously, we 
have shown that both human and mouse MAIT cells are stimulated by Ags, including 5-OP-
RU and 5-OE-RU, formed from the nonenzymatic reaction of a microbial riboflavin 
biosynthetic precursor with small metabolites (6, 9). H. pylori and other Helicobacter species 
contain an intact riboflavin biosynthesis pathway (Kyoto Encyclopedia of Genes and 
Genomes database), and thus were predicted to produce MAIT cell–stimulating riboflavin 
biosynthesis–derived Ags. Indeed, riboflavin production appears to be an essential metabolic 
pathway for H. pylori (35). To verify MAIT cell stimulation by H. pylori, we tested culture 
supernatant from H. pylori SS1 cultures for its ability to stimulate a reporter MAIT cell line, 
Jurkat.MAIT TRBV6-1 (9, 36). Similar to S. Typhimurium, previously shown to stimulate 
Jurkat.MAIT cells in this assay (6, 9), H. pyloriculture supernatant caused upregulation of 
CD69 on Jurkat.MAIT cells in the presence of MR1 expressed on C1R cells (C1R.MR1) 
(Fig. 1A). As with the activation previously demonstrated with S. Typhimurium supernatant 
(9) this could be specifically blocked with the anti-MR1 mAb 26.5, but not an isotype control 
mAb (Fig. 1A), indicating that there is minimal nonspecific MAIT cell activation. 
Importantly, Jurkat cells expressing an irrelevant TCR (Jurkat.LC13) were not activated 
under the same conditions (Fig. 1B). These data indicated that H. pylori are capable of 
producing a MAIT cell–stimulating Ag, which is presented by MR1. In addition, H. 
pylorisupernatant caused upregulation of MR1 on C1R.MR1 cells (Fig. 1C), similar to that 
previously demonstrated with S. Typhimurium supernatant or synthetic MR1 ligands (9, 37), 
a further confirmation of the presence of MR1-binding Ag. 
 
MAIT cells are present in the human gastric mucosa 
 
Booth et al. (19) recently reported the presence of MAIT cells in human gastric biopsies 
detected with CD161 and TRAV1-2 markers. To confirm their observation, we examined 
stomach tissue obtained from patients following sleeve gastrectomy bariatric procedures by 
immunofluorescence microscopy. In three patients we observed CD3+TRAV1-2+ cells within 
the gastric mucosa in close proximity to H. pylori (Fig. 2A). As we previously reported, a 
proportion of TRAV1-2+ cells are not MAIT cells, as judged by MR1-tetramer staining (3). 
Thus, we examined single cell preparations by flow cytometry using MR1-tetramers. MAIT 
cells could be detected in single cell preparations of gastric tissue where they represented 
∼1% (0.4–2.39) of T cells (Fig. 2B, 2C). Costaining with TRAV1-2 Ab and MR1-tetramer 
confirmed that the majority of TRAV1-2+CD161+CD3+ cells were MAIT cells (Fig. 2D). 
Interestingly, there was a higher proportion of MR1-tetramer−,TRAV1-2+ cells in the gastric 
tissue (∼25%), whereas in PBMCs almost all TRAV1-2+ cells were also MR1-tetramer+, thus 
highlighting the importance of defining MAIT cells using MR1-tetramers, particularly in 
studies involving cells isolated from tissues. Notably, there was a trend toward higher MAIT 
cell percentage in both PBMCs and gastric mucosae in patients where H. pylori were 
observed (Fig. 2C) 
 
H. pylori infection in mice increases MAIT cell numbers in the stomach 
 
The presence of MAIT cells in gastric tissue and the ability of H. pylori to activate 
Jurkat.MAIT cells in vitro suggest a potential role for MAIT cells in the immune response 
to H. pyloriinfection. To test this experimentally, in a model allowing controlled infection, 
we directly assessed the behavior and function of MAIT cells in the mouse model of H. 
pylori SS1 infection (29). MAIT cells are rare in naive, SPF-housed wt C57BL/6 mice 
compared with humans. In the stomach of naive mice they represent only ∼1% of αβ T 
lymphocytes and <∼100 MAIT cells are recovered from each stomach (Fig. 3A, 3B). In 
mice, there are no MAIT cell–specific Abs and thus MR1-tetramers are necessary for MAIT 
cell detection. To determine if MAIT cells increase in number in response to H. 
pylori infection in vivo, we infected C57BL/6 mice with 107 CFU H. pylori SS1 orally, and 
examined the MAIT cells in stomachs by flow cytometry, with MR1-tetramers, 12 wk 
postinfection. To assess pathology, histological assessment by H&E staining was conducted. 
Sections were scored blindly for cellular infiltration (neutrophilic and lymphocytic) and 
atrophy, a classical characteristic of chronic gastritis where there is a loss of chief and parietal 
cells, and a critical step in the development of gastric cancer (38 
 
There was a significant increase in the number of MAIT cells, detected with MR1-tetramers, 
in the stomachs of infected mice compared with naive controls (Fig. 3A, 3B, left panel). An 
increase in non-MAIT αβ T cells was also observed in both infected wt mice and in 
MR1−/− mice, which lack MAIT cells, compared with uninfected mice (Fig. 3B, right panel). 
Although no significant differences in absolute T cell numbers or gastric pathology scores 
(Fig. 3D) were observed between wt and MR1−/− mice (Fig. 3B, 3C), the absolute number of 
MAIT cells, but not non-MAIT αβ T cells, correlated with an increase in gastric atrophy at 12 
wk postinfection (Fig. 3C), suggesting a role for MAIT cells in driving pathology during 
chronic H. pylori infection. 
 
An increase in gastric MAIT cells upon H. pylori infection of Vα19iCα−/−MR1+ mice is 
associated with severe pathology 
 
Given the low numbers of T cells that can be isolated from naive stomachs, the analysis of 
MAIT cells is difficult in wt mice. Hence, we reasoned that increasing MAIT cell numbers 
would facilitate investigation of the role of these cells in immune protection or pathology in a 
bacterial infection where a complex immune response exists. One way to examine this is with 
the use of MAIT TCR transgenic mice (Vα19iCα−/−MR1+), which have been used previously 
because of the low numbers of MAIT cells in wt SPF mice (28). MAIT cells from 
Vα19iCα−/−MR1+mice are abundant, produce IFN-γ and TNF, and proliferate in vitro in 
response to specific MAIT cell Ag 5-OP-RU (3). 
 
Accordingly, we infected Vα19iCα−/− transgenic mice on MR1+ and MR1−/− backgrounds 
with H. pylori and then isolated single cell suspensions from the stomachs for flow 
cytometric analysis of MAIT cells at several time points. Following infection with H. pylori, 
MR1-tetramer reactive cells significantly increased as a proportion of αβ T cells from ∼30% 
to ∼60%, and in absolute numbers, by 4 wk postinfection in the Vα19iCα−/−MR1+ mice as 
compared with the control Vα19iCα−/−MR1−/− mice, and remained high at 12 wk 
postinfection (Fig. 4A–C). MR1-tetramers are highly specific for MAIT cells, but in 
Vα19iCα−/− mice, where the TCR repertoire is abnormally skewed toward selection of the 
MAIT Vα, a small proportion of “MAIT-like” cells also bind. These are thought to be MHC-
restricted (14). A small population of these cells was noted in Vα19iCα−/−MR1−/− mice (Fig. 
4A–C). Overall, the increase in tetramer-positive cells in Vα19iCα−/−MR1+ mice upon 
infection suggests that MAIT cells are capable of responding not only to H. pylori Ags in 
vitro, but also to infection in vivo. 
 
We next determined whether MAIT cells accumulating in the stomach during chronic H. 
pyloriinfection contribute to pathology. For this, Vα19iCα−/−MR1+ mice and 
Vα19iCα−/−MR1−/− mice were infected with H. pylori and stomachs processed for histological 
assessment by H&E staining at various time points postinfection. Sections were scored 
blindly for cellular infiltration (neutrophilic and lymphocytic) and atrophy. An increased 
cellular infiltrate was seen in the stomachs of Vα19iCα−/−MR1+ mice relative to 
Vα19iCα−/−MR1−/− mice at 12 wk (Fig. 4A, 4D), consistent with the increase in MAIT cells 
identified by tetramer staining (Fig. 4B, 4C), and as early as 2 wk in some mice (data not 
shown). By 12 wk postinfection, most Vα19iCα−/−MR1+mice developed severe atrophy (Fig. 
4D, 4E), suggesting that MAIT cells not only accumulate postinfection, but also contribute to 
pathology. 
 
Prior expansion of MAIT cells in wt mice results in greater MAIT cell accumulation in 
stomachs following H. pylori infection 
 
MAIT cell accumulation and concomitant enhanced pathology was observed in 
Vα19iCα−/−MR1+MAIT TCR transgenic mice suggesting a role for MAIT cells in this 
process. Given the vastly expanded number of MAIT cells in these mice, it was important to 
confirm this finding in wt mice. Inbred wt SPF-housed mice have fewer MAIT cells in the 
blood than humans, and it has been hypothesized that a history of natural infections in 
humans boost MAIT cell numbers (39). Less than 100 MAIT cells were recoverable in single 
cell suspensions from the stomachs of naive wt C57BL/6 mice (0.5–1% stomach T cells) 
(Fig. 3A, 3B), compared with ∼1–3% in the human gastric mucosa (19) (Fig. 2B). We 
reasoned that boosting MAIT cell numbers in wt C57BL/6 mice by prior bacterial infection 
might expand MAIT cells, recapitulating the case in humans, and hence reveal their role in 
gastric infection as observed in the Vα19iCα−/−MR1+mice. 
 
For this purpose, we used a recently developed model of MAIT cell enrichment in wt 
C57BL/6 mice (1) that involves either intranasal infection with S. Typhimurium or 
coinoculation of MAIT Ag and TLR agonists. Following boosting, MAIT cells rapidly 
expand in an MR1-dependent manner, comprising ∼50% of T cells in the lungs at day 7 
postinfection. Moreover, MAIT cells are redistributed to other organs and tissues, and their 
frequencies remain elevated up to 10 wk postinfection (1). Thus, we consider that this model 
more closely resembles MAIT cell distribution in adult humans where a history of infection 
and bacterial colonization may lead to a greater number of MAIT cells than observed in SPF-
housed mice. In order to determine the effect of boosting MAIT cell numbers on 
subsequent H. pylori infection, wt C57BL/6 mice were infected with S. Typhimurium 
BRD509 and after 6–10 wk, when the Salmonella bacteria are cleared to below detectable 
levels, mice were challenged by gastric infection with H. pylori SS1 (Fig. 5A). As expected, 
prior pulmonary infection with Salmonella not only expanded the proportion of MAIT cells 
in the lungs and blood of infected mice, but also in the stomachs (Fig. 5B). Notably, in the 
stomach, the proportion of MAIT cells increased to ∼6% of T cells (Fig. 5B). When 
preprimed mice were subsequently challenged with H. pylori, there was an increase in MAIT 
cell numbers as early as 2 wk postinfection with a significant increase over time (Fig. 5C 
 
Stomach MAIT cells induced following H. pylori infection exhibit a Tc17/Tc1 profile 
 
We next examined the phenotype of the MAIT cells accumulating after H. pylori infection in 
mice that were preboosted with S. Typhimurium. MAIT cells isolated from both the lungs 
and the stomach retained an “effector memory” phenotype, as previously described (1, 24), 
being CD44+ and CD62Llo (Fig. 6A). The majority of gastric MAIT cells expressed CD69 
and CD103, consistent with a tissue-resident phenotype (19) (Fig. 6B); this was also true for 
non-MAIT αβ T cells accumulating in the stomach after 8 wk of infection with H. 
pylori. There was a preferential accumulation of CD8+ MAIT cells in the stomach (Fig. 6C) 
and multiplex PCR and sequencing of single cells showed a TCR repertoire consistent with 
MAIT cells (Table I). MAIT cells are known to express a transcriptional signature that 
includes the regulators PLZF, RORγt, and T-bet. Following H. pylori infection we found that 
stomach MAIT cells showed a mixture of PLZF+ and PLZF−, as well as RORγt+ and 
RORγt− cells. In most MAIT cells there was coordinated expression of these two markers, 
with approximately half of all MAIT cells in mice infected with H. pylori lacking detectable 
expression of either transcription factor (Fig. 7). T-bet was expressed on almost all MAIT 
cells after H. pylori infection (87–98% in primed and H. pylori–infected, and 91–93% in H. 
pylori only) (Fig. 7), and the small number of cells lacking T-bet were either RORγt and 
PLZF positive or negative. Thus, MAIT cells accumulating in the stomach after H. 
pylori infection have a transcription factor profile consistent with Tc17/Tc1-type cells 
characteristic of proinflammatory capability. 
 
MAIT cells are important for early recruitment of other T cells 
 
In order to understand the implications of MAIT cell accumulation during gastric infection, 
we examined the effect of MAIT cell induction on the non-MAIT αβ T cell response. In 
preprimed mice the increase in MAIT cells was accompanied by an increase in non-MAIT αβ 
T cells, observed at 8 and 12 wk postinfection. The infiltration of non-MAIT T cells was 
delayed in mice lacking MR1 (C57BL/6.MR1−/−), indicating an MR1-dependent and 
therefore likely MAIT cell–driven effect on T cell recruitment (Fig. 8A). An important 
consideration is that, in addition to MAIT cell activation, Salmonella infection is expected to 
prime a complex immune response. To address this, we infected mice with a mutant strain 
of S. Typhimurium BRD509 in which key genes involved in riboflavin 
synthesis, ribD and ribH, are deleted (Salm.ΔribDH) (1). These mice did not accumulate 
MAIT cells in their stomachs following subsequent H. pylori infection (Fig. 8B). However, 
the response could be rescued when BRD509ΔribDH was supplemented with synthetic 5-
OP-RU Ag (Fig. 8B). This is consistent with our previous studies, which showed that MAIT 
cell responses are dependent on microbial riboflavin metabolites (1, 6, 9). The non-MAIT αβ 
T cell accumulation was also partially dependent on the presence of 5-OP-RU, supplied either 
by the riboflavin producing S. Typhimurium BRD509 bacteria or by adding exogenous 
synthetic ligand (Fig. 8C), suggesting a role of MAIT cells for recruiting other T cells. 
Similar to our previous observations in the lung model (1), this result could be reproduced by 
intranasal introduction of the specific MAIT cell Ag 5-OP-RU and a costimulus such as the 
TLR2/6 agonist S-[2,3-bis(palmitoyloxy)propyl] cysteine (Pam2Cys) (40). In contrast, MAIT 
and non-MAIT αβ T cell accumulation was much less apparent when Pam2Cys was 
combined intranasally with the MR1 ligand 6-formyl pterin (6-FP, a folate metabolite), which 
does not stimulate MAIT cells (9) (Fig. 8D, 8E). Thus, Ag-specific priming of MAIT cells 
leads to accumulation of non-MAIT T cells in the stomach upon H. pylori infection above the 
direct accumulation caused by infection or TLR ligation in the absence of MAIT cell Ag. 
 
Boosting MAIT cells in wt mice leads to accelerated pathology 
 
T cells and other cell types, including neutrophils and macrophages, have been implicated in 
pathology (gastritis) following H. pylori infection in humans and mouse models (41, 42). In 
mice preprimed with either S. Typhimurium BRD509 or Pam2Cys plus 5-OP-RU, and then 
infected with H. pylori, we observed, in addition to MAIT cell (Figs. 5C, 8) and non-MAIT 
αβ T cell (Fig. 8) accumulation, an increase in other immune cells including neutrophils, 
macrophages, eosinophils, and dendritic cells (Fig. 9A–D). This increase was significantly 
higher than in similarly primed and infected MR1−/− mice, indicating a role for MAIT cells in 
the recruitment of other cell types. The MAIT cell accumulation and recruitment of other cell 
types was associated with gastritis, which was evident on H&E-stained stomach sections 
(Fig. 9E), and in significantly increased pathology scores in wt mice, compared with 
MR1−/− mice, for lymphocytic infiltrate and atrophy. Strikingly, all MAIT preboosted wt 
mice infected with H. pylori developed atrophic gastritis by 8 wk postinfection (Fig. 9F); 
comparatively, only 2 of 5 MR1−/− mice developed atrophic gastritis (score 1 out of 4). 
Gastritis was also observed following H. pylori infection in wt mice primed with riboflavin-
deficient S. Typhimurium (Salm.ΔribDH) or with Pam2Cys, but this was significantly 
increased when the specific MAIT Ag 5-OP-RU was also added (Fig. 10), further 
demonstrating that MR1-Ag dependent MAIT cell activation drives gastric pathology. 
 
DISCUSSION 
 
We, and others (19), have observed the presence of MAIT cells in human gastric mucosae, 
prompting us to examine the role of MAIT cells in chronic H. pylori infection in mouse 
models. This study demonstrates, through a number of lines of evidence, that MAIT cells 
play an important role in gastric pathology following H. pylori infection. In wt C57BL/6 
mice, following H. pylori SS1 infection, the absolute numbers of MAIT cells, as well as non-
MAIT αβ T cells were increased in the stomach, and there was a correlation between MAIT 
cell numbers and pathology. Given that MAIT cells were virtually undetectable in stomachs 
of uninfected SPF-housed wt C57BL/6 mice, we next examined Vα19iCα−/−MR1+ TCR 
transgenic mice. In these mice a rapid MR1-dependent expansion of MAIT cells, which are 
already in high percentage in these mice in homeostasis, was observed following gastric 
infection. The attendant early onset of severe atrophic gastritis again suggested the 
association of MAIT cells and pathology. 
 
To verify the pathogenic role of MAIT cells observed in transgenic mice, we built on our 
established lung infection model (1), with two methods (Salmonella infection and synthetic 
5-OP-RU Ag/TLR agonist) to boost MAIT cell numbers prior to infection with H. pylori, on 
the basis that prior expansion of these cells is integral to their impact, and may reflect the 
case in humans with a history of infections. In this model, MAIT cells are distributed to many 
different tissues and organs after resolution of a primary lung infection (1). We hypothesize 
that a previous history of infection of this kind can prime MAIT cells and increase their 
numbers. Indeed, we observed increased MAIT cells in the stomach of wt mice after a 
primary lung infection, possibly because of mucosal homing markers expressed on MAIT 
cells and a shared cytokine/chemokine milieu between the mucosae of the lungs and stomach 
(43, 44). 
 
We show that when MAIT cells from wt C57BL/6 mice are primed first with either S. 
Typhimurium or with specific 5-OP-RU Ag and a TLR agonist, they subsequently respond 
rapidly upon challenge with H. pylori (∼10-fold increase in MAIT cell numbers at 2 wk 
postinfection) and these mice develop severe inflammation, recapitulating what was observed 
with the MAIT TCR transgenic mice. This was also the case in mice primed with TLR 
agonist plus synthetic 5-OP-RU Ag rather than Salmonella infection, but not TLR agonist 
alone. There was no change in MAIT cell proportions in the mesenteric lymph nodes 
following H. pylori infection of S. Typhimurium–primed mice (data not shown), indicating a 
gastric tissue–specific effect. These mice developed atrophic gastritis as early as 8 wk 
postinfection, which is normally not observed in wt C57BL/6 mice infected with H. 
pylori. The response was specific to MAIT cells and dependent on MR1. The accumulation 
of MAIT cells in the stomach showed a biased enrichment of CD8+ MAIT cells that was not 
seen in the blood. This could be due to upregulation of CD8, as the cytokine milieu has been 
shown to influence CD8 expression on CD4+ T intraepithelial lymphocytes (45), or it might 
reflect preferential expansion of CD8+ MAIT cells. 
 
Consistent with MAIT cells in other tissues and previous studies (1, 19, 24), we observed that 
MAIT cells in the stomach have an effector memory phenotype, characterized by 
CD44hiCD62Llo expression. A large proportion (∼50–70%) expressed the tissue-resident 
memory markers CD69 and CD103, consistent with observations on cells isolated from H. 
pylori–infected stomachs (19), and reflecting the chronic nature of H. pylori infection. MAIT 
cells isolated from infected stomachs also showed high expression of T-bet, consistent with a 
Th1-biased immune response to H. pylori, and similar to that observed after acute bacterial 
lung infection (1). Interestingly, T-bet–deficient mice exhibit a higher bacterial load, but 
lower levels of gastritis after H. pylori infection, indicating that a Th1-biased response may 
be important for both protection and immunopathology (46). PLZF and RORγt were both 
expressed on ∼50% of stomach MAIT cells following H. pylori infection of primed mice. 
Comparison with primed uninfected mice, and mice infected with H. pylori alone revealed 
that this transcriptional profile was driven primarily by H. pylori infection, with minimum 
effect of the prior S. Typhimurium priming. Thus, H. pylori infection appears to drive a 
Tc1/Tc17 transcriptional profile in responding MAIT cells. Although MAIT cells in the 
stomachs of naive mice were too few to be included in this analysis, the lower expression of 
these transcription factors following infection differs from that seen previously in either naive 
or S. Typhimurium–infected lungs, where the majority of MAIT cells expressed PLZF and 
RORγt (1). This difference may result from reprogramming of MAIT cell cytokine profiles, 
the preferential expansion of MAIT cell subsets under different tissue-specific cytokine 
milieu during chronic stimulation, or other signals that differ between the two pathogens. 
Interestingly, NK T cells can downregulate PLZF in adipose tissue because of chronic 
activation (47). To our knowledge, this is the first description of such a marked shift in the 
expression pattern of these transcription factors by MAIT cells, and the first demonstration of 
enrichment of Tc1/Tc17 MAIT cells. 
 
A number of studies using a range of mouse models have shown a Th1/Th17type T cell 
response in H. pylori (22, 23). The cytokines TNF, IFN-γ, and IL-17 are well established to 
have proinflammatory activity during infection (48–50). MAIT, and to a lesser extent non-
MAIT αβ T cells in our study, showed mixed RORγt+ and RORγt− populations and high T-
bet expression. Although technical difficulties precluded detection of cytokine production by 
stomach MAIT cells, the high T-bet expression suggests MAIT cells likely express IFN-γ 
in H. pylori–infected stomachs, consistent with a role for this cytokine in driving pathology. 
Importantly, we showed that the presence of MAIT cells was accompanied by infiltration of 
innate immune cells, as well as increased numbers of non-MAIT αβ T cells in the earlier 
stages of infection. This was associated with the severe gastritis phenotype observed in wt 
C57BL/6 mice with preboosted MAIT cells, and MAIT TCR transgenic mice, infected 
with H. pylori. Previous studies have shown that T cells are major orchestrators of 
inflammation (22, 23, 51). Interestingly, IFN-γ– and IL-17A–deficient mice exhibited 
reduced gastritis in previous H. pylori infection studies, consistent with a role for MAIT or 
other cell types in orchestrating pathology (52). Given the low numbers of MAIT cells in 
stomachs, they likely mediate their pathogenic effect through other cell types rather than 
directly. The impact of MAIT cells on the function of other cells, and, in particular, their 
production of key mediators of inflammation in H. pylori infection, such as IL-8 (53), for 
example, requires further investigation. Their impact on IgA production would also be 
worthy of further investigation. 
 
In summary, we show for the first time, to our knowledge, that in H. pylori–induced gastritis 
MAIT cells can play a pathogenic role in orchestrating immunopathology. This study clearly 
demonstrates, in vivo, that MAIT cells have the potential to drive inflammation and 
pathology during chronic bacterial infection, and this is likely associated with MAIT cells’ 
capacity to produce inflammatory cytokines, including IFN-γ, IL-17, and TNF. Notably, in 
humans only ∼20% of infected individuals develop overt disease, and the other factors at 
play are only partially understood. It is conceivable that the penetrance of severe gastritis 
in H. pylori–infected humans is influenced by a previous history of infections, and resultant 
MAIT cell priming, possibly at other mucosal sites. The recognition of a common MR1-
restricted Ag, derived from bacterial riboflavin synthesis, suggests that MAIT cells may be an 
important factor in modulating inflammation in Helicobacter and other chronic bacterial 
infections. Our findings also indicate that previous infections or vaccination, such as with live 
attenuated S. Typhi (54), may activate MAIT cells and predispose an individual to subsequent 
immunopathology when other comorbidities are present. 
 
 
  
Fig 1 
 
 
H. pylori culture supernatant stimulates a MAIT cell line. (A) In vitro activation of Jurkat.MAIT cells 
by filtered S. Typhimurium SL1344 (Salm., gray bars) or H. pylori SS1 (black or dotted bars) 
supernatant (s/n) or media controls (Luria broth [LB] or BHI respectively, striped bars) in a coculture 
assay with C1R.MR1 cells with or without MR1 blockade (mAb 26.5 or isotype control 8A5). 
Activation was detected by staining with anti-CD69. *p , 0.0001, one-way ANOVA with Sidak 
multiple comparisons test. (B) Activation of control Jurkat.LC13 cells cultured with C1R.HLA-B8 
cells with H. pylori s/n (black bars) or 285 nM FLRGRAYGL peptide from EBV (FLR, gray bar). 
Data show mean fluorescence intensity (MFI) (mean 6 SEM) of gated Jurkat.MAIT or Jurkat.LC13 
cells from three independent experiments. **p = 0.0007, one-way ANOVA with Dunnett multiple 
comparisons test.  (C) MR1 expression on gated C1R.MR1 cells following overnight incubation with 
H. pylori s/n or BHI media. Data show MFI minus background (nil stimulus) (mean 6 SEM from 
three experiments performed in duplicate). *p , 0.05, two-tailed Student t test 
 
 
 
  
Fig 2 
  
MAIT cells are observed in human gastric mucosa in proximity to H. pylori. (A) Immunofluorescence 
staining of human gastric tissue from sleeve gastrectomy patients. CD3 (magenta), TRAV1-2 (green), 
H. pylori (red), nuclear stain (blue). Original magnification 3100. CD3+TRAV1-2+ cells (white 
arrows), CD3+TRAV1-22 cell (magenta arrows), H. pylori (red arrows). Multiple sections from three 
patients showed similar results. (B and C) MAIT cells detected by flow cytometry in PBMCs or single 
cell suspensions of gastric tissue from five patients. Gate shows MAIT cells, defined as 
CD3+CD45+CD161+MR1-tetramer+ live cells. Numbers indicate the MAIT cell percentage of live 
CD3+ lymphocytes. Scatter plots show individual points and mean. (D) Costaining with TRAV1-2 
and MR1-tetramer. Plots show PBMCs and gastric lymphocytes from patient 4, gated on MR1-
tetramer+CD161+ cells or on TRAV1-2+CD161+ cells. Bottom panels show gated cells stained for 
the opposite marker. 
 
 
 
 
 
Fig 3 
 
 
MAIT cell infiltration in a proportion of wt mice infected with H. pylori. (A) Representative plots 
showing MAIT and non-MAIT TCRb+cells in wt and MR12/2 mice at 12 wk postinfection with H. 
pylori. (B) Absolute numbers of MAIT cells and non-MAIT ab T cells from the stomachs of wt and 
MR12/2 mice infected with H. pylori at 12 wk or uninfected (mean 6 SEM; n = 5 MR12/2, 8 wt for 
uninfected and n = 15 MR12/2, 28 wt for infected). ***p , 0.0001, one-way ANOVA with Sidak 
multiple comparisons test. (C) Scatter plot depicting the Spearman correlation coefficient for the 
absolute numbers of MAIT cells (left) or non-MAIT ab T cells (right) and atrophy scores of wt mice 
at 12 wk postinfection. (D) Pathology scores of wt and MR12/2 mice at 12 wk postinfection. Sections 
were scored for neutrophilic infiltration, lymphocytic infiltration, and atrophy (Kruskal–Wallis test). 
The experiment was performed three times with similar results. 
 
 
 
 
Fig 4 
 
MAIT cell overexpressing mice show greater pathology following H. pylori infection. (A) 
Representative plots showing MAIT and non-MAIT CD3+ cells in Va19iCa2/2MR1+ and 
Va19iCa2/2MR12/2 mice at 12 wk postinfection with H. pylori. (B) MAIT cells as a percentage of 
CD3+T cells, and (C) as absolute numbers in Va19iCa2/2MR1+ and Va19iCa2/2MR12/2 mice over a 
time course of 2–12 wk postinfection. The experiment was performed three times with similar results: 
five to eight mice per group were examined (mean 6 SEM). *p , 0.005, ***p , 0.0001, one-way 
ANOVA with Dunnett multiple comparisons test. (D) Pathology scores of Va19iCa2/2MR1+ and 
Va19iCa2/2MR12/2 mice at 12 wk postinfection. Sections were scored for neutrophilic infiltration, 
lymphocytic infiltration, and atrophy. *p , 0.05, Kruskal–Wallis test. (E) Representative 
photomicrographs of H&Estained sections of mouse stomachs showing infected Va19iCa2/2MR1+ 
(with severe gastritis), uninfected Va19iCa2/2MR1+ (normal), and infected Va19iCa2/2MR12/2 
(normal architecture), original magnification 350 
 
 
 
 
Fig 5 
 
MAIT cells expand in response to H. pylori infection in wt C57BL/6 mice after prepriming. (A) 
Schematic depicting the model used for the experiments. (B) Percentage of MAIT cells in different 
organs 7 wk after intranasal infection with S. Typhimurium BRD509. (C) Absolute numbers of MAIT 
cells from the stomachs of wt mice infected with S. Typhimurium BRD509, and then challenged (at 7 
wk) with H. pylori or left unchallenged over time (n = 5–8). The experiments were performed three 
times with similar results. ***p , 0.0001, one-way ANOVA with Sidak multiple comparisons test 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6 
 
Characterization of the phenotype of MAIT cells following infection. Analysis of (A) effector 
memory (CD62L and CD44) and (B) tissue residency (CD103 and CD69) marker expression on 
MAIT cells and non-MAIT T cells isolated from the lungs and stomachs of S. Typhimurium–primed 
mice infected with H. pylori (or left uninfected) at 8 wk postinfection. (C) CD4+, CD8+, and CD4, 
CD8 double negative (DN) MAIT cells expressed as a percentage of total MAIT cells in the blood and 
stomachs of S. Typhimurium–primed mice, challenged or not with H. pylori at 8 wk post–H. pylori 
infection. The experiments were performed three times with similar results. Representative plots are 
shown. 
 
 
 
  
Fig 7 
 
(A) Representative plots and (B) scatterplots for individual transcription factor expression by MAIT 
cells and non-MAIT ab T cells isolated from lungs and stomachs of S. Typhimurium–primed H. 
pylori–infected mice at 12 wk postinfection (each dot represents data from two to three pooled mice). 
(C) Representative plots and (D) stacked plots for transcription factor combinations on gated MAIT 
cells isolated from the stomachs of S. Typhimurium–primed, primed and H. pylori–infected (at 12 wk 
postinfection) or H. pylori–infected mice (at 18 wk postinfection) (mean 6 SEM). The experiments 
were performed at least twice with similar results. 
 
 
 
 
 
 
Fig 8 
 
MAIT cells orchestrate accumulation of other T cells in the gastric mucosa. (A) Absolute numbers of 
non-MAIT ab T cells from the stomachs of wt and MR12/2 mice infected with S. Typhimurium 
BRD509 (Salm.), and then challenged (at 7 wk) with H. pylori or left unchallenged over time 
(comparisons between wt and MR12/2: *p , 0.05, **p , 0.001, one-way ANOVA with Sidak multiple 
comparisons test; comparisons between time points: **p , 0.005, ****p , 0.0001, one-way ANOVA 
with Dunnett multiple comparisons test; n = 5–8). Data are from the same experiment shown in Fig. 
5C. (B–E) Absolute numbers of MAIT cells (B and D) and non-MAIT ab T cells (C and E) from 
stomachs of wt and MR12/2 mice primed with S. Typhimurium BRD509 (Salm.) or BRD509DribDH 
(Salm.DribDH) plus or minus 5-OP-RU (B and C) or Pam2Cys plus either 5-OP-RU or 6-FP (D and 
E), and then either challenged with H. pylori or left unchallenged (data shown are 8 wk post–H. pylori 
infection). The experiment was performed twice with similar results. Data show mean 6 SEM (n = 5–
8). *p , 0.05, **p , 0.001, one-way ANOVA 
 
 
 
 
 
 
Fig 9 
 
 
 
Prior expansion of MAIT cells leads to recruitment of innate immune cells in wt mice and reveals 
pathological role in H. pylori infection. Absolute numbers of neutrophils (A), macrophages (B), 
eosinophils (C), and dendritic cells (D) from stomachs of wt and MR12/2 mice infected with S. 
Typhimurium BRD509 (Salm.) or Pam2Cys plus 5-OP-RU, and then challenged with H. pylori (at 7 
wk) or left unchallenged over time (n = 5–8). *p , 0.05, **p , 0.001, ***p , 0.0001, one-way ANOVA 
with Sidak multiple comparisons test. (E) Representative photomicrographs of H&E-stained sections 
of mouse stomachs from wt mice immunized with S. Typhimurium BRD509 (Salm.) (showing normal 
mucosa), and S. Typhimurium BRD509 (Salm.) primed H. pylori–challenged wt mice (severe 
gastritis) and MR12/2 mice (mild inflammation), original magnification 350. (F) Pathology scores of 
S. Typhimurium–primed wt and MR12/2 mice at 8 wk post–H. pylori infection. Sections were scored 
for neutrophilic infiltration, lymphocytic infiltration, and atrophy. Scores from one experiment are 
shown. The experiment was performed three times with similar results. *p , 0.05, Kruskal–Wallis test 
 
 
 
 
 
 
 
 
Fig 10 
 
 
 
Pathology scores of wt and MR12/2 mice primed with S. Typhimurium BRD509 (Salm.) or 
BRD509DribDH (Salm.DribDH) (A) or Pam2Cys and 5-OP-RU or 6-FP (B) then challenged with H. 
pylori or left unchallenged at 8 wk post–H. pylori infection. Sections were scored for neutrophilic 
infiltration, lymphocytic infiltration, and atrophy (n = 5–8). The experiments were performed twice 
with similar results. *p , 0.05, Kruskal–Wallis test. 
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